Literature DB >> 9376517

Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease.

F Boissière1, S Hunot, B Faucheux, C Duyckaerts, J J Hauw, Y Agid, E C Hirsch.   

Abstract

NF-kappaB is a nuclear transcription factor involved in the control of numerous cellular functions, particularly regulation of survival. Translocation from the cytoplasm to the nucleus, an event essential for NK-kappaB activation, could be mediated through the low-affinity nerve growth factor receptor, p75, which has recently been shown to mediate cell death. In the human brain, p75 is exclusively expressed in cholinergic neurons of the basal forebrain. This population degenerates in Alzheimer's disease (AD). To investigate whether p75 could play a role in the vulnerability of these neurons via NF-kappaB activation, we studied the cellular distribution of NF-kappaB in the nucleus basalis of Meynert of four AD patients and four control subjects. The immunostaining observed both in AD patients and control subjects was limited to large, probably cholinergic, neurons. In AD, the proportion of neurons with nuclear NF-kappaB staining was significantly increased, suggesting an association between NF-kappaB functions and the process of cholinergic degeneration in AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376517     DOI: 10.1097/00001756-199709080-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  45 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Expression of superoxide dismutase messenger RNA in adult rat brain cholinergic neurons.

Authors:  C Kent; K Sugaya; D Bryan; D Personett; M McKinney
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

3.  Ginsenoside Rd Improves Learning and Memory Ability in APP Transgenic Mice.

Authors:  Juanfang Liu; Xiaodong Yan; Ling Li; Yuan Li; Linfu Zhou; Xiaohui Zhang; Xinghua Hu; Gang Zhao
Journal:  J Mol Neurosci       Date:  2015-09-10       Impact factor: 3.444

Review 4.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

5.  Palmitate-induced C/EBP homologous protein activation leads to NF-κB-mediated increase in BACE1 activity and amyloid beta genesis.

Authors:  Gurdeep Marwarha; Jared Schommer; Jonah Lund; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2018-02-14       Impact factor: 5.372

Review 6.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

7.  Low-level laser therapy for beta amyloid toxicity in rat hippocampus.

Authors:  Yujiao Lu; Ruimin Wang; Yan Dong; Donovan Tucker; Ningjun Zhao; Md Ejaz Ahmed; Ling Zhu; Timon Cheng-Yi Liu; Robert M Cohen; Quanguang Zhang
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

Review 8.  NF-kappaB in the survival and plasticity of neurons.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

9.  Salubrinal attenuates β-amyloid-induced neuronal death and microglial activation by inhibition of the NF-κB pathway.

Authors:  Xiumei Huang; Yaomin Chen; Han Zhang; Qilin Ma; Yun-wu Zhang; Huaxi Xu
Journal:  Neurobiol Aging       Date:  2011-11-05       Impact factor: 4.673

10.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.